Baragi VM - Search Results

1

A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.

Baragi VM, Becher G, Bendele AM, Biesinger R, Bluhm H, Boer J, Deng H, Dodd R, Essers M, Feuerstein T, Gallagher BM Jr, Gege C, Hochgürtel M, Hofmann M, Jaworski A, Jin L, Kiely A, Korniski B, Kroth H, Nix D, Nolte B, Piecha D, Powers TS, Richter F, Schneider M, Steeneck C, Sucholeiki I, Taveras A, Timmermann A, Van Veldhuizen J, Weik J, Wu X, Xia B. Baragi VM, et al. Arthritis Rheum. 2009 Jul;60(7):2008-18. doi: 10.1002/art.24629. Arthritis Rheum. 2009. PMID: 19565489 Free article.

2

Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.

Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM. Gege C, et al. Among authors: baragi vm. J Med Chem. 2012 Jan 26;55(2):709-16. doi: 10.1021/jm201152u. Epub 2012 Jan 10. J Med Chem. 2012. PMID: 22175799

3

Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats.

Renkiewicz R, Qiu L, Lesch C, Sun X, Devalaraja R, Cody T, Kaldjian E, Welgus H, Baragi V. Renkiewicz R, et al. Arthritis Rheum. 2003 Jun;48(6):1742-9. doi: 10.1002/art.11030. Arthritis Rheum. 2003. PMID: 12794843 Free article.

4

Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats.

Baragi VM, Qiu L, Gunja-Smith Z, Woessner JF Jr, Lesch CA, Guglietta A. Baragi VM, et al. Scand J Gastroenterol. 1997 May;32(5):419-26. doi: 10.3109/00365529709025075. Scand J Gastroenterol. 1997. PMID: 9175201

5

A protocol for rapid screening of proteoglycan-degrading metalloproteinase inhibitors.

Baragi VM, Jordan H, Renkiewicz RR. Baragi VM, et al. J Pharmacol Toxicol Methods. 1992 Apr;27(2):101-5. doi: 10.1016/1056-8719(92)90028-y. J Pharmacol Toxicol Methods. 1992. PMID: 1591401

6

Regulation of osteoclast differentiation by statins.

Grasser WA, Baumann AP, Petras SF, Harwood HJ Jr, Devalaraja R, Renkiewicz R, Baragi V, Thompson DD, Paraklar VM. Grasser WA, et al. Among authors: baragi v. J Musculoskelet Neuronal Interact. 2003 Mar;3(1):53-62. J Musculoskelet Neuronal Interact. 2003. PMID: 15758366 Free article.

7

Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.

Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Hartman JW, Roessler BJ. Baragi VM, et al. J Clin Invest. 1995 Nov;96(5):2454-60. doi: 10.1172/JCI118303. J Clin Invest. 1995. PMID: 7593634 Free PMC article.

8

A versatile assay for gelatinases using succinylated gelatin.

Baragi VM, Shaw BJ, Renkiewicz RR, Kuipers PJ, Welgus HG, Mathrubutham M, Cohen JR, Rao SK. Baragi VM, et al. Matrix Biol. 2000 Jul;19(3):267-73. doi: 10.1016/s0945-053x(00)00086-x. Matrix Biol. 2000. PMID: 10936451

9

Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo.

Baragi VM, Renkiewicz RR, Qiu L, Brammer D, Riley JM, Sigler RE, Frenkel SR, Amin A, Abramson SB, Roessler BJ. Baragi VM, et al. Osteoarthritis Cartilage. 1997 Jul;5(4):275-82. doi: 10.1016/s1063-4584(97)80023-4. Osteoarthritis Cartilage. 1997. PMID: 9404472 Free article.

10

Confocal laser scanning immunofluorescence imaging for quantitation of stromelysin in human synovial fibroblasts.

Baragi VM, Brott DA, Qiu L, Conroy MC, Lalwani ND. Baragi VM, et al. Ann N Y Acad Sci. 1994 Sep 6;732:348-50. doi: 10.1111/j.1749-6632.1994.tb24749.x. Ann N Y Acad Sci. 1994. PMID: 7978804 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page